Note E - Consolidation of Variable Interest Entity - Pro Forma Financial Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Sales Revenue, Goods, Net	$ 10,482,005	$ 9,491,569
Cost of Goods Sold	4,175,533	3,048,260
Gross Profit	6,306,472	6,443,309
Selling, general and administrative expenses	11,549,961	9,399,201
Research and development expenses	1,270,471	100,856
Operating expenses	12,820,432	9,500,057
Loss from operations	(6,513,960)	(3,056,748)
Other (expenses)	(5,088)	(5,347)
Interest income	1,285	3,838
Loss before provision for income tax and equity in net earnings of equity investments	(6,517,763)	(3,058,257)
Provision for Income Tax	(19,101)	36,157
Loss before equity in net earnings of equity investments	(6,498,662)	(3,094,414)
Income (Loss) from Equity Method Investments	(795,827)	(2,445,489)
Net Losses	(7,294,489)	(5,539,903)
Less: Net loss attributable to the noncontrolling interests	1,347,982	72,381
Net loss attributable to Milestone Scientific Inc.	(5,946,507)	(5,467,522)
Milestone China [Member]
Income (Loss) from Equity Method Investments	(795,827)	$ (418,432)
Milestone Medical Inc. & Milestone Education LLC [Member] | Pro Forma [Member]
Sales Revenue, Goods, Net	9,624,375
Cost of Goods Sold	3,061,299
Gross Profit	6,563,076
Selling, general and administrative expenses	12,781,813
Research and development expenses	892,255
Operating expenses	13,674,068
Loss from operations	(7,110,992)
Other (expenses)	(6,845)
Interest income	3,846
Loss before provision for income tax and equity in net earnings of equity investments	(7,113,991)
Provision for Income Tax	(36,157)
Loss before equity in net earnings of equity investments	(7,150,148)
Income (Loss) from Equity Method Investments	(418,432)
Net Losses	(7,568,580)
Less: Net loss attributable to the noncontrolling interests	2,101,056
Net loss attributable to Milestone Scientific Inc.	(5,467,524)
Milestone Medical Inc. & Milestone Education LLC [Member] | Pro Forma [Member] | Milestone China [Member]
Income (Loss) from Equity Method Investments	$ (418,432)